US-based Filipino chemist Dr. Webster L. Santos has discovered and patented a groundbreaking new class of small-molecule drugs for treating acute kidney injury (AKI) and autoimmune diseases. In an ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company’s investigational RNA interference (RNAi) therapeutic targeting ...

U.S. total addressable market for five initial indications is $25 to $33 billionREMINDER: Business Update Conference Call begins at 4:30 p.m.

VMPL Gurugram Haryana [India] 11 Demonstrating its commitment to advanced healthcare Park Hospital Gurugram has successfully ...

Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone ...

Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone ...

Q32 Bio still sees potential for its anti-IL-7R antibody as an alopecia treatment despite failing a phase 2 eczema study—but ...

Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart ...

Clinicians treating patients with kidney disease must be aware of dental considerations to avoid potentially lethal consequences.

Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative ...

Since 2011, the Capital Area Dental Foundation has given free dental care to Season for Caring families. They need more ...

Vertex Pharmaceuticals Incorporated looks set for two new drug approvals in early 2025. Click here to read an analysis of ...